Legal Representation
Attorney
Tim Rogers
USPTO Deadlines
Next Deadline
64 days remaining
NOA E-Mailed - SOU Required
Due Date
March 30, 2026
Extension Available
Until September 30, 2026
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 3, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 3, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 28, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 5, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 21, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 21, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 21, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 21, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 23, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 23, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 23, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 23, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 23, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 23, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 20, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 20, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 20, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 20, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 17, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 13, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 1, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Antioxidants for medical purposes, namely, antioxidants for use in the manufacture of pharmaceuticals
Class 005
Antipyretic, analgesic, and anti-inflammatory preparations; Pharmaceutical preparations for the treatment of COVID-19 coagulopathy, COVID-19 cytokine storm, acute myocardial infarction, acute thrombotic stroke, Mild to Moderate pain and Moderate to Severe Pain; Veterinary preparations, namely, antipyretics, analgesics, anti-inflammatories preparations and antioxidants
Class 042
Health and medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of research of health issues and research of pharmaceutical products; Veterinary health and medical information services, namely, providing information to veterinarians, medical professionals and owners on the topics of research of health issues and research of pharmaceutical products
Class 044
Health and medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health care issues and diagnostic, prophylactic and therapeutic properties of pharmaceutical products; Veterinary health and medical information services, namely, providing information to veterinarians, medical professionals and owners on the topics of health care issues and diagnostic, prophylactic and therapeutic properties of pharmaceutical products
Classification
International Classes
001
005
042
044